Antihypertensives. Diagnostic category

Similar documents
Management of Hypertension

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Antihypertensive drugs SUMMARY Made by: Lama Shatat

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

sympatholytics sympatholytics sympatholytics

Section 3, Lecture 2

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

ANTI- HYPERTENSIVE AGENTS

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension. Penny Mosley MRPharmS

Hypertension (JNC-8)

Beta 1 Beta blockers A - Propranolol,

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

M2 TEACHING UNDERSTANDING PHARMACOLOGY

Hypertension Management - Summary

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP

Cardiac Pathophysiology

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Antihypertensive drugs: I. Thiazide and other diuretics:

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

Summary of recommendations

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

By Prof. Khaled El-Rabat

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Heart Failure (HF) Treatment

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Therefore MAP=CO x TPR = HR x SV x TPR

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to

5.2 Key priorities for implementation

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Categories of HTN. Overview of Hypertension. Types of Hypertension

Treatment of Essential Hypertension

What in the World is Functional Medicine?

Byvalson. (nebivolol, valsartan) New Product Slideshow

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

Hypertension: an overview of recommended treatment John Vann Jones PhD, FRCP

Antihypertensive Agents

Managing Hypertension in 2016

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None


- Dr Alia Shatnawi. 1 P a g e

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

STANDARD treatment algorithm mmHg

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Creative blood pressure management: whys and the tricks

hypertension Head of prevention and control of CVD disease office Ministry of heath

Antihypertensive Agents

Hypertension: GP guide to recommended treatment Gordon McInnes MD, FRCP and John Vann Jones PhD, FRCP

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Cardiovascular drugs

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Heart Failure Clinician Guide JANUARY 2018

Treatment of Essential Hypertension

만성콩팥병환자에서의혈압관리 분당서울대병원신장내과 안신영

Antihypertensive Agents

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

COMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5

TREATMENT OF HYPERTENSION

Jared Moore, MD, FACP

Difficult to Treat Hypertension

Cardiovascular Pharmacotherapy

Presentation of hypertensive emergency

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Heart Failure Clinician Guide JANUARY 2016

Heart Failure. Dr. Alia Shatanawi

ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR.

Functional vascular disorders

Fundamentals of Pharmacology for Veterinary Technicians Chapter 8

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

Antihypertensive Drugs. Nafrialdi

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?

LESSON ASSIGNMENT. After completing this lesson you will be able to:

Network Hypertension Algorithm

HEART FAILURE SUMMARY. and is associated with significant morbidity and mortality. the cornerstone of heart failure treatment.

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100

Chapter 2 ~ Cardiovascular system

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology

Approach to Management of Hypertension. Prof. Abdulkareem Al-Suwaida, MD, FRCPC, MSc

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

LXIV: DRUGS: 4. RAS BLOCKADE

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Low Efficacy Diuretics. Potassium sparing diuretics. Carbonic anhydrase inhibitors. Osmotic diuretics. Miscellaneous

Prof. Ramzy H. El Mawardy. Cairo Egypt 2009

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Transcription:

Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient has been standing for at least 2 minutes. Diagnosis of should be based on multiple BP measurements taken on separate occasions. If systolic and diastolic fall into different categories, patient falls into the more severe category. In patients with, take history and perform physical examination to: Identify all cardiovascular risk factors. Detect end-organ damage and related conditions. Identify causes of secondary. Diagnostic category Systolic Diastolic Follow up (mmhg) (mmhg) Normal <120 <80 Recheck in 2 years High normal 120 139 80 89 Recheck in 1 year Grade 1 (mild) 140 159 90 99 Confirm within 2 months Grade 2 (moderate) 160 179 100 109 Reassess or refer within 1 month Grade 3 (severe ) 180 110 Reassess or refer within 1 7 days as necessary Isolated systolic 140 < 90 As for category corresponding to systolic BP Isolated systolic with widened pulse pressure 160 70 As for grade 3 Essential Secondary 90% 10% Aetiology unknown Secondary to abnormality or drug Risk factors: genetics, smoking, stress, environment, diet. Renal disease, drugs, coarctation of aorta, Conn s, Cushing s, phaeochromocytoma. coarctation of aorta Conn s Cushing s phaeochromocytoma Lifestyle risk reduction Antihypertensive drug treatment for aorta narrows in area where ligamentum arteriosum inserts hyperaldosteronism (aldosterone mineralcorticoid) glucocorticoid excess tumour releasing adrenaline/noradrenaline Especially in high normal BP group. Continue in conjunction with drug treatment Exercise, smoking cessation, waist measurement, BMI, dietary salt restriction, limit alcohol intake. Grade 3 Isolated systolic with widened pulse pressure Associated conditions or evidence of end-organ damage (regardless of BP) High absolute risk of cardiovascular disease

waist measurement <9 4cm for men, < 80cm for women BMI < 25kg/m 2 dietary salt 4g/day alcohol 2 standard drinks /day for men, 1 standard drink /day for women Target end organ damage Due to per se Due to atherosclerosis dissecting aortic aneurysm Heart, brain, kidney, retina, dissecting aortic aneurysm. Coronary arteries, cerebral arteries, carotids, others. tear in inner layer of blood vessel blood surges through causes inner and middle layers to separate Increased peripheral resistance due to plaque and hypertrophy increase vessel wall thickness and decrease lumen diameter increases risk of acute MI, angina, cerebral infarct BP = CO x TPR = SV x HR x TPR choice of antihypertensives depends on patient s CV risk profile presence of organ damage presence of coexisting conditions (diabetes, respiratory) individual patient variability adverse effects interactions with co-prescribed drugs cost and simplicity

Class Drugs Mechanism Effects Indications Adverse effects Contraindications ACE captopril block ACE ang II formation, vasodilation TPR renal artery stenosis inhibitor enalapril block bradykinin breakdown avoid in pregnancy ARB renin inhibitors β blockers (β1 & β2 nonselective) β blockers (β1 selective) perindopril losartan irbesartan candesartan aliskiren propranolol atenolol metoprolol ang II, bradykinin AT 1 receptor antagonist inhibit action of ang II ang II, bradykinin level unchanged inhibit enzyme renin angii, bradykinin symp drive to heart HR, TPR CO inhibit renin release ang II if lipid soluble symp outflow from CNS Na +,K + -ATPase activity Na + and water excretion aldosterone secretion Na +,K + -ATPase activity Na + and water excretion HR, TPR CO ang II heart failure diabetic nephropathy diabetic neuropathy angina post MI arrhythmias clinically stable heart failure (carvedilol) cough (ACEI, bradykinin), headache, marked hypotension, hyperkalaemia hypotension hyperkalaemia bronchoconstriction (β2) heart contractility, bradycardia, atrioventricular block, exercise intolerance, claudication, impotence lipid soluble depression, sedation, sleep problems Ca 2+ channel blockers verapamil diltiazem nifedipine amlodipine block L-type Ca 2+ channels [Ca 2+ ] in vascular/cardiac cells dilation vasodilation cardiac contractility atrioventricular conduction verapamil has most significant cardiac effects angina tachyarrhythmia (SVT) exacerbate and mask hypoglycaemia in diabetics cardiac depression, bradycardia flushing, oedema, dizziness, headache constipation, nausea heart failure β blockers

Class Drugs Mechanism Effects Indications Adverse effects Contraindications diuretic hydrochlorothiazide short term: CO mild to moderate (thiazide) indapamide diuretic (loop) diuretic (K + sparing) frusemide spironolactone Na + excretion water excretion blood volume VR CO thiazide: block Na +,Cl - symport (distal tubule) loop: block Na +,K +,2Cl symport (thick ascending) K + sparing: block Na +,Cl - symport (collecting tubules and ducts) long term CO returns to normal, TPR oedema due to mild/moderate congestive heart failure diabetes insipidus electrolyte imbalance hypokalaemia (drug interactions) hyperuricaemia hyperchesteraemia hyperglycaemia diabetogenic effect Class Drug / type Action / adverse effects Indications endothelin blockers sildenafil (Viagra) not effective in primary used in pulmonary other sympathetic blockers ganglion blockers, adrenergic neurone blockers not well tolerated interfere with reflex function α 1 blocker suicidal tendencies first dose syncope postural hypotension reflex tachycardia urinary urgency CNS acting brain α 2 receptors sedation, depression, rebound on withdrawal other vasodilators hydralazine interferes with Ca 2+ release from SR co-treatment: and benign prostate hyperplasia cromokalim increases K + permeability - minoxidil for hair growth minoxidil hyperpolarise sodium nitroprusside generates NO i.v. for emergency treatment of drug interactions with digoxin (digitalis) increase toxicity

angiotensin II action aldosterone action reduce hypotension why hyperkaelemia diabetic nephropathy why ACEI and ARB contraindicated in renal artery stenosis which may cause angioedema β adrenergic receptor subtypes claudication SVT diabetes insipidus diuretics for diabetes insipidus? wtf? why do thiazides cause hypokalaemia hyperuricaemia (gout) body s most powerful Na + retaining hormone stimulates Na +,K + -ATPase vasoconstriction stimulates aldosterone secretion stimulates Na +,K + -ATPase start with low dose Na +,K + -ATPase antiport. block Na + reabsorption block K + excretion angiopathy of kidney glomeruli due to diabetes mellitus ACEI and ARB reduce GFR reduce kidney function exacerbate renal impairment in patients with renal artery stenosis, especially if taken with NSAIDs and diuretic. ACEI. due to bradykinin. infrequent and depends on genetic predisposition rate of bradykinin degradation β1 heart and kidneys β2 lungs, GI, liver, uterus, vascular smooth muscle, skeletal muscle β3 fat cells painful, aching, cramping, uncomfortable, or tired feeling in the legs that occurs during walking and is relieved by rest supraventricular tachycardia originate above ventricular tissue. ventricular tachycardia more deadly a condition characterised by excessive thirst and excretion of large amounts of severely diluted urine, with reduction of fluid intake having no effect on the latter. dunno man, paradoxical effect block Na + reabsorption in distal tubule high [Na + ] at collecting ducts aldosterone cause Na + reabsorption and K + and H + secretion at collecting duct abnormally high level of uric acid in blood

Drug treatment for guidelines 1. Na + and alcohol restriction, weight control 2. diuretic or β blocker or Ca 2+ antagonist or ACEI/ARB 3. Add 2 nd drug of different class or increase dose of 1 st drug or substitute another drug 4. Add 3 rd drug of different class or substitute another drug 5. Further evaluation and/or 3 rd or 4 th drug Most patients will not achieve BP target with monotherapy. Combinations may allow control with smaller doses less dose-dependent adverse effects. Particular role in presence of most effective ACEI or ARB Ca 2+ channel blocker diabetes or lipid anomalies combination other combinations ACEI or ARB thiazide heart failure or stroke ACEI or ARB beta blocker post MI heart failure beta blocker Ca 2+ channel blocker coronary heart disease (nifedipine) thiazide beta blocker not recommended in people with glucose intolerance, metabolic syndrome or diabetes avoid combination ACEI/ARB K + sparing diuretic risk of hyperkalaemia verapamil beta blocker risk of heart block